Showing results (71-80 of 92) with videos related to
Sort By:
Pageof 10
Wiener Klinische Wochenschrift|August 23, 2018
Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer : A retrospective analysisEva Asamer, Joanna Szkandera, Paul Gibiser, et al.Cancer Medicine|June 16, 2020
External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patientsDominik Andreas Barth, Carina Brenner, Jakob Michael Riedl, et al.Journal of Clinical Medicine|December 23, 2023
Incidence of Diabetes Mellitus and Its Impact on Outcomes in Patients Undergoing Surgical Pancreatectomy for Non-Malignant and Malignant Pancreatobiliary Diseases-A Retrospective AnalysisAnna Schranz, Christoph Sternad, Faisal Aziz, et al.World Journal of Surgery|October 15, 2013
Preparing for prospective clinical trials: a national initiative of an excellence registry for consecutive pancreatic cancer resectionsOdo Gangl, Klaus Sahora, Peter Kornprat, et al.Cancers|July 9, 2020
The Lipase/Amylase Ratio (LAR) in Peripheral Blood Might Represent a Novel Prognostic Marker in Patients with Surgically Resectable Pancreatic CancerMichael Stotz, Dominik A Barth, Jakob M Riedl, et al.Cancers|May 8, 2020
Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer PatientsEva Valentina Klocker, Dominik Andreas Barth, Jakob Michael Riedl, et al.Plos One|November 14, 2013
External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patientsJoanna Szkandera, Michael Stotz, Florian Eisner, et al.Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|August 28, 2023
Clinical Impact of Stump Closure Reinforced With Hemopatch on the Prevention of Clinically Relevant Pancreatic Fistula After Distal Pancreatectomy: A Multicenter Randomized TrialSelman Uranues, Abraham Fingerhut, Orlin Belyaev, et al.Plos One|November 10, 2017
SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer typesGeorg Richtig, Ariane Aigelsreiter, Daniela Schwarzenbacher, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 29, 2018
Exploring the surgical landscape of pancreatic neuroendocrine neoplasia in Austria: Results from the ASSO pNEN study groupFlorian Primavesi, Eckhard Klieser, Benno Cardini, et al.Pageof 10